JBIO insider transaction filings
Jade Biosciences, Inc. — 19 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-26. Screen JBIO transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-26 | 4 | Eisner Mark — Director | Grant/award (A): 47,675 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | CAIN CHRISTOPHER W. — Director | Grant/award (A): 34,843 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Klein Lawrence Otto — Director | Grant/award (A): 34,843 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Lavelle Erin — Director | Grant/award (A): 34,843 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Fairmount Funds Management LLC — Director, 10% owner Fairmount Healthcare Fund II L.P. — Director, 10% owner Fairmount Healthcare Co-Invest IV L.P. — Director, 10% owner Kiselak Tomas — Director, 10% owner Harwin Peter Evan — Director, 10% owner | Grant/award (A): 34,843 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | DOBMEIER ERIC — Director | Grant/award (A): 34,843 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Balta Elizabeth — See Remarks | Grant/award (A): 28,125 @ $0 · Grant/award (A): 168,750 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Frohlich Tom — Chief Executive Officer, Director | Grant/award (A): 78,750 @ $0 · Grant/award (A): 472,500 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | King Andrew James — See Remarks | Grant/award (A): 41,250 @ $0 · Grant/award (A): 247,500 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Dahms Bradford D. — Chief Financial Officer | Grant/award (A): 37,813 @ $0 · Grant/award (A): 226,875 (derivative) @ $0 | EDGAR |
| 2025-10-08 | 4 | Fairmount Funds Management LLC — Director, 10% owner Fairmount Healthcare Fund II L.P. — Director, 10% owner Fairmount Healthcare Co-Invest IV L.P. — Director, 10% owner Kiselak Tomas — Director, 10% owner Harwin Peter Evan — Director, 10% owner | Grant/award (A): 1,333,126 @ $9.14 · Grant/award (A): 855,047 (derivative) @ $9.14 | EDGAR |
| 2025-07-14 | 4 | Dahms Bradford D. — Chief Financial Officer | Grant/award (A): 526,000 (derivative) @ $0 | EDGAR |
| 2025-05-19 | 4 | Frohlich Tom — Chief Executive Officer, Director | Purchase (P): 6,000 @ $7.40 | EDGAR |
| 2025-05-01 | 4 | CAIN CHRISTOPHER W. — Director | Grant/award (A): 23,017 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | Klein Lawrence Otto — Director | Grant/award (A): 23,017 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | Lavelle Erin — Director | Grant/award (A): 23,017 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | Fairmount Funds Management LLC — Director, 10% owner Fairmount Healthcare Fund II L.P. — Director, 10% owner Kiselak Tomas — Director, 10% owner Harwin Peter Evan — Director, 10% owner | Grant/award (A): 23,017 (derivative) @ $0 | EDGAR |
| 2025-05-01 | 4 | DOBMEIER ERIC — Director | Grant/award (A): 23,017 (derivative) @ $0 | EDGAR |
| 2025-04-30 | 4 | RA CAPITAL MANAGEMENT, L.P. — 10% owner RA Capital Healthcare Fund LP — 10% owner Kolchinsky Peter — 10% owner Shah Rajeev M. — 10% owner | Other (J): 1,062,326 | EDGAR |
Recent 8-K events — Jade Biosciences, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-01 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
| 2026-06-26 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-11 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-01 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-22 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-04-02 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-03-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=JBIO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →